Teva Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Teva Pharma (TEVA) Reports In-Line Q2 EPS; Lowers Revenue Outlook
July 28, 2021 7:06 AM EDTTeva Pharma (NYSE: TEVA) reported Q2 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $3.9 billion versus the consensus estimate of $4.04 billion.
GUIDANCE:
Teva Pharma sees FY2021 EPS of $2.50-$2.70, versus the consensus of... More
